HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Biological properties of a CD4 immunoadhesin.

Abstract
Molecular fusions of CD4, the receptor for human immunodeficiency virus (HIV), with immunoglobulin (termed CD4 immunoadhesins) possess both the gp120-binding and HIV-blocking properties of recombinant soluble CD4, and certain properties of IgG, notably long plasma half-life and Fc receptor binding. Here we show that a CD4 immunoadhesin can mediate antibody-dependent cell-mediated cytotoxicity (ADCC) towards HIV-infected cells, although, unlike natural anti-gp120 antibodies, it does not allow ADCC towards uninfected CD4-expressing cells that have bound soluble gp120 to the CD4 on their surface. In addition, CD4 immunoadhesin, like natural IgG molecules, is efficiently transferred across the placenta of a primate. These observations have implications for the therapeutic application of CD4 immunoadhesins, particularly in the area of perinatal transmission of HIV infection.
AuthorsR A Byrn, J Mordenti, C Lucas, D Smith, S A Marsters, J S Johnson, P Cossum, S M Chamow, F M Wurm, T Gregory, J E Groopman, D J Capon
JournalNature (Nature) Vol. 344 Issue 6267 Pg. 667-70 (Apr 12 1990) ISSN: 0028-0836 [Print] England
PMID1970124 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.)
Chemical References
  • Antibodies, Anti-Idiotypic
  • Antigens, CD
  • CD4 Immunoadhesins
  • HIV Envelope Protein gp120
  • Immunoglobulin G
  • Recombinant Proteins
Topics
  • Acquired Immunodeficiency Syndrome (congenital, immunology)
  • Animals
  • Antibodies, Anti-Idiotypic (immunology)
  • Antibody-Dependent Cell Cytotoxicity (immunology)
  • Antigens, CD (immunology)
  • CD4 Immunoadhesins
  • CD4-Positive T-Lymphocytes (immunology, microbiology)
  • Female
  • HIV (immunology)
  • HIV Envelope Protein gp120 (immunology)
  • Humans
  • Immunity, Maternally-Acquired
  • Immunoglobulin G (immunology)
  • Macaca mulatta
  • Pregnancy
  • Recombinant Proteins

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: